(Q31007816)

English

Prediction of oral clearance from in vitro metabolic data using recombinant CYPs: comparison among well-stirred, parallel-tube, distributed and dispersion models

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Prediction of oral clearance from in vitro metabolic data using recombinant CYPs: comparison among well-stirred, parallel-tube, distributed and dispersion models (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

author name string

T Yamamoto

1

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

H Itoga

2

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Y Kohno

3

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

K Nagata

4

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Y Yamazoe

5

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

language of work or name

0 references

publication date

1 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

627-646

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Physiologically based models and strategic experiments in hepatic pharmacology

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Role of human liver microsomal CYP2C9 in the biotransformation of lornoxicam

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: Extrapolation of data to benzodiazepines and phenytoin

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Absolute bioavailability of clarithromycin after oral administration in humans

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Animal scale-up

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Clarithromycin clinical pharmacokinetics

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Prediction of in vivo drug disposition from in vitro data based on physiological pharmacokinetics

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Automated high throughput ADME assays for metabolic stability and cytochrome P450 inhibition profiling of combinatorial libraries

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Utility of Hepatocytes in Predicting Drug Metabolism: Comparison of Hepatic Intrinsic Clearance in Rats and Humans in Vivo and in Vitro

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Pharmacokinetic studies on the selective beta1-receptor antagonist metoprolol in man.

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations.

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Correlation between in-vitro microsomal enzyme activity and whole organ hepatic elimination kinetics: analysis with a dispersion model

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

A High-Throughput Method for Enzyme Kinetic Studies

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Clinical pharmacokinetics of lornoxicam. A short half-life oxicam

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Metabolism of N,N-dipropyl-2-[4-methoxy-3-(2-phenyl-ethoxy)-phenyl]-ethyl-amine-monohydrochloride (NE-100), a novel sigma ligand: contribution of cytochrome P450 forms involved in the formation of individual metabolites in human liver and small inte

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Differences in cytochrome P450 forms involved in the metabolism of N,N-dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethylamine monohydrochloride (NE-100), a novel sigma ligand, in human liver and intestine

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Prediction of differences in in vivo oral clearance of N,N-dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl] ethylamine monohydrochloride (NE-100) between extensive and poor metabolizers from in vitro metabolic data in human liver microsomes lacking C

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

High-throughput screening to estimate single or multiple enzymes involved in drug metabolism: microtitre plate assay using a combination of recombinant CYP2D6 and human liver microsomes

1 reference

https://api.crossref.org/works/10.1080%2F00498250500159371

21 January 2018

Identifiers

10.1080/00498250500159371

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31007816&oldid=1646993582"